- Yale Center for Infectious Disease200 Orchard StreetNew Haven, CT 06511
Amit Achhra, MPH, PhD, MD
Infectious Diseases, HIV & AIDs Medicine
Telehealth is available
Patient type treated
Child, Adult
Accepting new patients
Yes
Referral required
Not Applicable
Board Certified in
Internal Medicine and Infectious Disease
Titles
- Assistant Professor of Medicine (Infectious Diseases)
Education & Training
- FellowMass General Brigham/Harvard Medical School (2021)
- ResidentNYP/ Weill Cornell Medical Center (2019)
- InternMt Sinai School of Medicine (Bronx program) (2017)
- PhDUniversity of New South Wales (2012)
- MPHUniversity of Wollongong (2008)
- MDK J Somaiya Medical College, Maharashtra University of Health Sciences (2007)
Languages Spoken
- English
- हिन्दी (Hindi)
Additional Information
Honors & Recognitions
- Deans List Award – competitive award for outstanding research for Ph.D., UNSW, Australia: (2011)
- Kirby Institute/UNSW Scholarship for PhD for 3 years (total approx. USD 125,000): (2009)
- Distinction Award for MPH, University of Wollongong: (2008)
- TATA Trust Scholarship (nationally competitive 50% tuition fees for medical school) based on academic performance: (2005)
Board Certifications
- AB of Internal Medicine, Infectious Disease (2021)
- AB of Internal Medicine, Internal Medicine (2019)
Professional Service
- NBC CT (2023): Invited expert to discuss Doxy PEP for STIs
- Clinical Advisory Team of Connecticut Sexual Health Coalition (2023 - Present): Chair the Clinical Advisory Team on STIs and Mpox formed by CT DPH in response to STI epidemic in the CT state. Advisory team's input will help CT DPH make policy decisions to combat this epidemic.
- CT DPH (2023 - Present): Co-chair CT STI Clinical Advisory Board. Lead meetings with other clinicians and stakeholders in the CT state to discuss initiatives that can alleviate in ongoing STI epidemic.
- Yale School of Medicine (2022 - Present): I co-founded this monthly conference called "Ambulatory ID Rounds". It provides a platform for various clinicians to discuss their active complex cases and ask questions from their peers. Goal is to improve patient care and increase clinical learning in a collegial environment.
- Journal Of Infectious Diseases (2022 - Present): Reviewer
- Yale School of Medicine (2022 - Present): Infectious Disesaes Fellowship Program Evaluation Committee
- AIDS Research and Therapy (2017 - 2023): Associate Editor
- Clinical infectious diseases (CID); Journal of infectious diseases (JID); Diabetes care; BMJ Open; JAIDS; PLOS One; HIV Medicine; BMC infectious diseases; PLOS neglected and tropical diseases; Infectious agents and cancer (2012 - Present): Reviewer
Publications
- Pelchen-Matthews A, Mocroft A, Ryom L, Ross M, Sharma S, Coca S, Achhra A, Cornell E, Tracy R, Phillips A, Alonso M, Toulomi G, Agan B, Medland N, Wyatt C, Group I. Corrigendum to “Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.” Kidney International 2024;106:136–144. Kidney International 2024, 106: 1196. PMID: 39577998, DOI: 10.1016/j.kint.2024.10.002.
- Achhra A, Chan E, Applebaum S, Guerrero M, Hao R, Pantel H, Virata M, Fikrig M, Barakat L. Five-Year Evaluation of an Anal Cancer Screening Program in Men Who Have Sex With Men With HIV at 2 Academic Center Clinics. Clinical Infectious Diseases 2024, ciae541. PMID: 39492696, DOI: 10.1093/cid/ciae541.
- Pelchen-Matthews A, Mocroft A, Ryom L, Ross M, Sharma S, Coca S, Achhra A, Cornell E, Tracy R, Phillips A, Alonso M, Toulomi G, Agan B, Medland N, Wyatt C, Group I. Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV. Kidney International 2024, 106: 136-144. PMID: 38697479, PMCID: PMC11193627, DOI: 10.1016/j.kint.2024.04.010.
- Acute Hepatitis Due to Primary Human Immunodeficiency Virus InfectionOpen Forum Infectious Diseases, ofae170, https://doi.org/10.1093/ofid/ofae170 Published: 22 March 2024
- Elliott E, Smith D, Lipscomb J, Banini B, Meurer L, Vanderford T, Johnson J, Jain D, Achhra A. Acute Hepatitis due to Primary Human Immunodeficiency Virus Infection. Open Forum Infectious Diseases 2024, 11: ofae170. PMID: 38585186, PMCID: PMC10996125, DOI: 10.1093/ofid/ofae170.
- Palacios C, Achhra A, Barakat L, Virata M, Hao R, Baxter J, Malinis M. 1538. Is there value in performing yearly screening for latent tuberculosis infection by interferon-gamma release assay among patients living with HIV in non-endemic settings? Open Forum Infectious Diseases 2023, 10: ofad500.1373. PMCID: PMC10678242, DOI: 10.1093/ofid/ofad500.1373.
- Achhra A, Chan E, Applebaum S, Guerrero M, Hao R, Pantel H, Virata M, Barakat L. 1478. Evaluation Of Anal Cancer Screening Program in men who have sex with men (MSM) persons with HIV (PWH) At Two academic center HIV Clinics 2018-2022. Open Forum Infectious Diseases 2023, 10: ofad500.1314. PMCID: PMC10677807, DOI: 10.1093/ofid/ofad500.1314.
- Kyle K, Maher M, Achhra A, Venna N. Contrasting Cases of HIV Vasculopathy Associated Fusiform Aneurysms. The Neurohospitalist 2022, 13: 69-73. PMID: 36531848, PMCID: PMC9755620, DOI: 10.1177/19418744221122863.
- Achhra A, Phillips A, Emery S, MacArthur R, Furrer H, De Wit S, Losso M, Law M. O21.3 Pre-therapy inflammation/coagulation activation and long-term cd4 response to antiretroviral therapy. Sexually Transmitted Infections 2015, 91: a73.1-a73. DOI: 10.1136/sextrans-2015-052270.195.
- Achhra A, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith C, Monforte A, Phillips A, Weber R, Lundgren J, Law, Group T. Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Medicine 2015, 17: 255-268. PMID: 26216031, DOI: 10.1111/hiv.12294.
- Achhra A, Phillips A, Emery S, MacArthur R, Furrer H, De Wit S, Losso M, Law, groups I. Pre‐therapy inflammation and coagulation activation and long‐term CD4 count responses to the initiation of antiretroviral therapy. HIV Medicine 2015, 16: 449-454. PMID: 25959989, PMCID: PMC5676307, DOI: 10.1111/hiv.12258.
- Achhra A, Mocroft A, Ross M, Ryom L, Lucas G, Furrer H, Neuhaus J, Somboonwit C, Kelly M, Gatell J, Wyatt C, Group I. Kidney disease in antiretroviral‐naïve HIV‐positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine 2015, 16: 55-63. PMID: 25711324, PMCID: PMC4341947, DOI: 10.1111/hiv.12234.
- Achhra A, Amin J. Race and CD4+ T-cell count in HIV prognosis and treatment. Future Virology 2012, 7: 193-203. DOI: 10.2217/fvl.11.143.
Departments and Programs
Locations
- Yale Center for Infectious Disease200 Orchard StreetNew Haven, CT 06511
Titles
- Assistant Professor of Medicine (Infectious Diseases)
Education & Training
- FellowMass General Brigham/Harvard Medical School (2021)
- ResidentNYP/ Weill Cornell Medical Center (2019)
- InternMt Sinai School of Medicine (Bronx program) (2017)
- PhDUniversity of New South Wales (2012)
- MPHUniversity of Wollongong (2008)
- MDK J Somaiya Medical College, Maharashtra University of Health Sciences (2007)
Languages Spoken
- English
- हिन्दी (Hindi)
Additional Information
Honors & Recognitions
- Deans List Award – competitive award for outstanding research for Ph.D., UNSW, Australia: (2011)
- Kirby Institute/UNSW Scholarship for PhD for 3 years (total approx. USD 125,000): (2009)
- Distinction Award for MPH, University of Wollongong: (2008)
- TATA Trust Scholarship (nationally competitive 50% tuition fees for medical school) based on academic performance: (2005)
Board Certifications
- AB of Internal Medicine, Infectious Disease (2021)
- AB of Internal Medicine, Internal Medicine (2019)
Professional Service
- NBC CT (2023): Invited expert to discuss Doxy PEP for STIs
- Clinical Advisory Team of Connecticut Sexual Health Coalition (2023 - Present): Chair the Clinical Advisory Team on STIs and Mpox formed by CT DPH in response to STI epidemic in the CT state. Advisory team's input will help CT DPH make policy decisions to combat this epidemic.
- CT DPH (2023 - Present): Co-chair CT STI Clinical Advisory Board. Lead meetings with other clinicians and stakeholders in the CT state to discuss initiatives that can alleviate in ongoing STI epidemic.
- Yale School of Medicine (2022 - Present): I co-founded this monthly conference called "Ambulatory ID Rounds". It provides a platform for various clinicians to discuss their active complex cases and ask questions from their peers. Goal is to improve patient care and increase clinical learning in a collegial environment.
- Journal Of Infectious Diseases (2022 - Present): Reviewer
- Yale School of Medicine (2022 - Present): Infectious Disesaes Fellowship Program Evaluation Committee
- AIDS Research and Therapy (2017 - 2023): Associate Editor
- Clinical infectious diseases (CID); Journal of infectious diseases (JID); Diabetes care; BMJ Open; JAIDS; PLOS One; HIV Medicine; BMC infectious diseases; PLOS neglected and tropical diseases; Infectious agents and cancer (2012 - Present): Reviewer
Publications
- Pelchen-Matthews A, Mocroft A, Ryom L, Ross M, Sharma S, Coca S, Achhra A, Cornell E, Tracy R, Phillips A, Alonso M, Toulomi G, Agan B, Medland N, Wyatt C, Group I. Corrigendum to “Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.” Kidney International 2024;106:136–144. Kidney International 2024, 106: 1196. PMID: 39577998, DOI: 10.1016/j.kint.2024.10.002.
- Achhra A, Chan E, Applebaum S, Guerrero M, Hao R, Pantel H, Virata M, Fikrig M, Barakat L. Five-Year Evaluation of an Anal Cancer Screening Program in Men Who Have Sex With Men With HIV at 2 Academic Center Clinics. Clinical Infectious Diseases 2024, ciae541. PMID: 39492696, DOI: 10.1093/cid/ciae541.
- Pelchen-Matthews A, Mocroft A, Ryom L, Ross M, Sharma S, Coca S, Achhra A, Cornell E, Tracy R, Phillips A, Alonso M, Toulomi G, Agan B, Medland N, Wyatt C, Group I. Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV. Kidney International 2024, 106: 136-144. PMID: 38697479, PMCID: PMC11193627, DOI: 10.1016/j.kint.2024.04.010.
- Acute Hepatitis Due to Primary Human Immunodeficiency Virus InfectionOpen Forum Infectious Diseases, ofae170, https://doi.org/10.1093/ofid/ofae170 Published: 22 March 2024
- Elliott E, Smith D, Lipscomb J, Banini B, Meurer L, Vanderford T, Johnson J, Jain D, Achhra A. Acute Hepatitis due to Primary Human Immunodeficiency Virus Infection. Open Forum Infectious Diseases 2024, 11: ofae170. PMID: 38585186, PMCID: PMC10996125, DOI: 10.1093/ofid/ofae170.
- Palacios C, Achhra A, Barakat L, Virata M, Hao R, Baxter J, Malinis M. 1538. Is there value in performing yearly screening for latent tuberculosis infection by interferon-gamma release assay among patients living with HIV in non-endemic settings? Open Forum Infectious Diseases 2023, 10: ofad500.1373. PMCID: PMC10678242, DOI: 10.1093/ofid/ofad500.1373.
- Achhra A, Chan E, Applebaum S, Guerrero M, Hao R, Pantel H, Virata M, Barakat L. 1478. Evaluation Of Anal Cancer Screening Program in men who have sex with men (MSM) persons with HIV (PWH) At Two academic center HIV Clinics 2018-2022. Open Forum Infectious Diseases 2023, 10: ofad500.1314. PMCID: PMC10677807, DOI: 10.1093/ofid/ofad500.1314.
- Kyle K, Maher M, Achhra A, Venna N. Contrasting Cases of HIV Vasculopathy Associated Fusiform Aneurysms. The Neurohospitalist 2022, 13: 69-73. PMID: 36531848, PMCID: PMC9755620, DOI: 10.1177/19418744221122863.
- Achhra A, Phillips A, Emery S, MacArthur R, Furrer H, De Wit S, Losso M, Law M. O21.3 Pre-therapy inflammation/coagulation activation and long-term cd4 response to antiretroviral therapy. Sexually Transmitted Infections 2015, 91: a73.1-a73. DOI: 10.1136/sextrans-2015-052270.195.
- Achhra A, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith C, Monforte A, Phillips A, Weber R, Lundgren J, Law, Group T. Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. HIV Medicine 2015, 17: 255-268. PMID: 26216031, DOI: 10.1111/hiv.12294.
- Achhra A, Phillips A, Emery S, MacArthur R, Furrer H, De Wit S, Losso M, Law, groups I. Pre‐therapy inflammation and coagulation activation and long‐term CD4 count responses to the initiation of antiretroviral therapy. HIV Medicine 2015, 16: 449-454. PMID: 25959989, PMCID: PMC5676307, DOI: 10.1111/hiv.12258.
- Achhra A, Mocroft A, Ross M, Ryom L, Lucas G, Furrer H, Neuhaus J, Somboonwit C, Kelly M, Gatell J, Wyatt C, Group I. Kidney disease in antiretroviral‐naïve HIV‐positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Medicine 2015, 16: 55-63. PMID: 25711324, PMCID: PMC4341947, DOI: 10.1111/hiv.12234.
- Achhra A, Amin J. Race and CD4+ T-cell count in HIV prognosis and treatment. Future Virology 2012, 7: 193-203. DOI: 10.2217/fvl.11.143.
Departments and Programs
Locations
- Yale Center for Infectious Disease200 Orchard StreetNew Haven, CT 06511
- Yale Center for Infectious Disease200 Orchard StreetNew Haven, CT 06511